ACHC - Acadia Healthcare Company, Inc.
BlackRock Inc. bought a new position in Acadia Healthcare Company, Inc. (NASDAQ: ACHC) during the second quarter, according to the company in its most recent filing with the SEC. The firm bought 14,957,168 shares of the company's stock, valued at approximately $441,685,000. BlackRock Inc. owned 16.07% of Acadia Healthcare as of its most
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Acadia Healthcare Company is a leading pure-play behavioral healthcare provider with 279 facilities and a growing patient base. ACHC's revenue continues to climb, but profitability is pressured by rising labor costs and a tight labor market. Despite higher net leverage and volatile cash flows, shares appear attractively priced on an absolute basis.
Acadia Healthcare Investigation Continued: Kahn Swick and Foti, LLC Continues to Investigate the Officers and Directors of Acadia Healthcare Compa
NEW ORLEANS, Aug. 21, 2026 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq.
Acadia Healthcare is rated BUY, driven by a robust capacity expansion pipeline and strong macro demand for mental health services. ACHC's defensible moat stems from its scale—279 facilities, 12.6k beds—positioning it as the largest independent U.S. behavioral healthcare provider. Forward EV/EBITDA of 8.8x reflects a 30% discount to the sector median and 17% below its five-year average, supporting valuation upside.
ACHC's premium valuation faces a key test as facility growth and stronger EBITDA guidance compete with rising costs and weaker returns.
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into Acadia Healthcare Company, Inc. (NasdaqGS: ACHC). On September 27, 2024, the Company disclosed the receipt of a voluntary request for information from the U. S. Attorney's Office for the Southern District of New York as well as a grand jury subpoena from the United States District Cour.
On August 06, 2026, Acadia Healthcare Co Inc (ACHC) shares fell 4.7% today, closing at $30.73. The stock has exhibited significant volatility over the past year
SAN DIEGO, July 31, 2026 /PRNewswire/ -- Robbins LLP reminds investors of their rights following the court's decision to allow securities claims against Acadia Healthcare Company (NASDAQ: ACHC) to proceed. The case is continuing after the Court denied defendants' motion to dismiss the amended complaint.
Acadia Healthcare Company, Inc. (ACHC) Q2 2026 Earnings Call Transcript
Acadia Healthcare NASDAQ: ACHC reported second-quarter 2026 results that management said were in line with expectations, supported by progress at recently opened facilities, disciplined spending and strong free cash flow generation.
ACHC beats Q2 earnings and revenue estimates as admissions rise and residential treatment grow, prompting higher 2026 guidance despite profit pressure.
Acadia Healthcare (ACHC) came out with quarterly earnings of $0.38 per share, beating the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.83 per share a year ago.
SAN DIEGO, July 28, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors of their rights following the court's decision to allow securities claims against Acadia Healthcare Company (NASDAQ: ACHC) to proceed. The case is continuing after the Court denied defendants' motion to dismiss the amended complaint.
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced financial results for the second quarter ended June 30, 2026. Second Quarter 2026 Results Revenue totaled $865.8 million, which was approximately flat compared with the second quarter of 2025. As described on page 2, total revenue growth in the second quarter was 2.8%1 after normalizing for prior period supplemental payment program revenue in each of the respective quarte.
SAN DIEGO--(BUSINESS WIRE)---- $ACHC #Medicine--Robbins LLP reminds investors of their rights following the court's decision to allow securities claims against Acadia Healthcare Company (NASDAQ: ACHC) to proceed.The case is continuing after the Court denied defendants' motion to dismiss the amended complaint. The ruling means the case can proceed past the motion-to-dismiss stage. It does not determine whether the allegations are true or establish liability. Investors who purchased or otherwise acquired Acadia Healt.
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its second quarter 2026 results on Tuesday, July 28, 2026, after the close of the market. Acadia will host a conference call with institutional investors and analysts on Wednesday, July 29, 2026 at 9:00 a.m. ET. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the “Investors” section of the website, and the archived webcast will be availabl.
The Zacks Medical-Hospital industry is adapting as care shifts beyond inpatient settings, demand rises and earnings outlook improves. THC, UHS, ACHC and CYH stand out.